ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
| 2.21 Delayed Data As of Oct 28 |  -0.09 / -3.91%Today’s Change | 1.80 Today|||52-Week Range 5.61 | -53.18% Year-to-Date |
Latest ZIOP News | Press Releases
No recent news for ZIOPHARM Oncology Inc.
Today’s Trading
| Previous close | 2.30 |
| Today’s open | 2.22 |
| Day’s range | 2.17 - 2.27 |
| Volume | 1,352,846 |
| Average volume (3 months) | 1,670,212 |
| Market cap | $484.0M |
Data as of 3:59pm ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | -43.55% |
| Earnings growth (this year) | +48.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| URGNUrogen Pharma Ltd | -0.63 | -2.79% |
| RCELAvita Therapeutics I... | -1.61 | -6.96% |
| FIXXHomology Medicines I... | -0.57 | -5.10% |
| SIGASIGA Technologies In... | -0.08 | -1.23% |
Data as of 3:59pm ET, 10/28/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$117.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
